Peter Rahmer, See remarks at Relay Therapeutics, Inc. (RLAY), sold 12,103 shares at $3.17 ($37K) on 2025-04-28, disclosed to the SEC on 2025-04-30.
Open-market sale of $37k RLAY by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.17 | 1,364 | $4K | 11.8% |
| 2 | $3.00 | 10,739 | $32K | 88.2% |
| Total | $3.02 avg | 12,103 | $37K | 100% |
| Filing → |
| RLAY | SELL | 2026-07-02 | $955K | — | Filing → |
| RLAY | SELL | 2026-04-30 | $11K | — | Filing → |
| RLAY | SELL | 2026-01-29 | $100K | — | Filing → |